(EFX) Equifax - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2944291051

Credit Reports, Analytics, Identity Verification, Workforce Solutions, Debt Recovery

EFX EPS (Earnings per Share)

EPS (Earnings per Share) of EFX over the last years for every Quarter: "2020-09": 1.87, "2020-12": 2, "2021-03": 1.97, "2021-06": 1.98, "2021-09": 1.85, "2021-12": 1.84, "2022-03": 2.22, "2022-06": 2.09, "2022-09": 1.73, "2022-12": 1.52, "2023-03": 1.43, "2023-06": 1.71, "2023-09": 1.76, "2023-12": 1.81, "2024-03": 1.5, "2024-06": 1.82, "2024-09": 1.85, "2024-12": 2.12, "2025-03": 1.53, "2025-06": 2, "2025-09": 2.04,

EFX Revenue

Revenue of EFX over the last years for every Quarter: 2020-09: 1068.3, 2020-12: 1118.4, 2021-03: 1213, 2021-06: 1234.8, 2021-09: 1222.9, 2021-12: 1253.2, 2022-03: 1363.2, 2022-06: 1316.7, 2022-09: 1244.3, 2022-12: 1197.9, 2023-03: 1302, 2023-06: 1317.6, 2023-09: 1319.1, 2023-12: 1326.5, 2024-03: 1389.4, 2024-06: 1430.5, 2024-09: 1441.8, 2024-12: 1419.4, 2025-03: 1442, 2025-06: 1537, 2025-09: 1544.9,
Risk via 10d forecast
Volatility 32.2%
Value at Risk 5%th 48.1%
Reward
Sharpe Ratio -0.61
Alpha -44.43
Character
Hurst Exponent 0.403
Beta 1.587
Drawdowns 3y
Max DD 32.95%
Mean DD 11.96%

Description: EFX Equifax October 14, 2025

Equifax Inc. (NYSE:EFX) is a data, analytics, and technology firm organized into three primary business segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The company’s core competency is aggregating and delivering credit-related and other public-record information to both commercial and consumer clients.

The Workforce Solutions segment supplies verification services-income, employment, education, criminal history, healthcare licensure, and sanctions-for U.S. individuals, while also offering employers automated payroll and human-resource management tools that span the full employment lifecycle.

The U.S. Information Solutions segment delivers a suite of consumer and commercial products, including credit reports, credit scoring, portfolio analytics, fraud detection, identity verification, mortgage services, financial marketing, and credit-monitoring solutions. This segment also provides consulting and identity-management services to financial institutions.

The International segment extends similar credit-information and analytics offerings to markets in the Americas, Europe, Asia-Pacific, and the Middle East, and adds debt-collection, recovery-management, and HR process-automation services for businesses and governments. Equifax operates in more than 20 countries, with a footprint that includes the United States, Canada, the United Kingdom, Brazil, India, and several Latin-American nations.

Recent performance metrics (2023) show total revenue of approximately $5.0 billion, a 5 % year-over-year increase driven largely by growth in the USIS segment (+7 % YoY) and modest expansion in International (+3 % YoY). The credit-reporting industry’s size is estimated at $30 billion globally, with a projected CAGR of 4 % through 2028, supported by rising consumer debt levels and tighter regulatory scrutiny on identity-theft mitigation. A key macro driver is the Federal Reserve’s interest-rate policy: higher rates tend to increase credit-file activity (new loans, credit inquiries) and thus boost demand for Equifax’s data services, but also raise default risk, which can shift client focus toward fraud-prevention tools.

For a deeper, data-driven assessment of Equifax’s valuation assumptions and scenario analyses, you might explore the analytical dashboards on ValueRay, where the platform’s granular driver-based models can help you quantify the impact of interest-rate shifts and regulatory changes on the company’s earnings outlook.

EFX Stock Overview

Market Cap in USD 25,558m
Sub-Industry Research & Consulting Services
IPO / Inception 1971-05-11
Return 12m vs S&P 500 -32.6%
Analyst Rating 4.17 of 5

EFX Dividends

Dividend Yield 1.09%
Yield on Cost 5y 1.45%
Yield CAGR 5y 0.00%
Payout Consistency 92.1%
Payout Ratio 24.6%

EFX Growth Ratios

CAGR 2.55%
CAGR/Max DD Calmar Ratio 0.08
CAGR/Mean DD Pain Ratio 0.21
Current Volume 891.2k
Average Volume 1264.2k

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (658.6m TTM) > 0 and > 6% of Revenue (6% = 356.6m TTM)
FCFTA 0.08 (>2.0%) and ΔFCFTA 2.10pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -8.76% (prev -3.96%; Δ -4.80pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 1.47b > Net Income 658.6m (YES >=105%, WARN >=100%)
Net Debt (4.62b) to EBITDA (1.81b) ratio: 2.55 <= 3.0 (WARN <= 3.5)
Current Ratio 0.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (124.1m) change vs 12m ago -0.88% (target <= -2.0% for YES)
Gross Margin 56.26% (prev 55.52%; Δ 0.74pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 49.17% (prev 45.27%; Δ 3.90pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 5.15 (EBITDA TTM 1.81b / Interest Expense TTM 213.9m) >= 6 (WARN >= 3)

Altman Z'' 3.00

(A) -0.04 = (Total Current Assets 1.46b - Total Current Liabilities 1.98b) / Total Assets 11.83b
(B) 0.54 = Retained Earnings (Balance) 6.33b / Total Assets 11.83b
(C) 0.09 = EBIT TTM 1.10b / Avg Total Assets 12.09b
(D) 0.89 = Book Value of Equity 6.02b / Total Liabilities 6.76b
Total Rating: 3.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 68.34

1. Piotroski 7.50pt = 2.50
2. FCF Yield 3.31% = 1.66
3. FCF Margin 16.82% = 4.20
4. Debt/Equity 0.97 = 2.05
5. Debt/Ebitda 2.55 = -1.04
6. ROIC - WACC (= -2.02)% = -2.53
7. RoE 13.29% = 1.11
8. Rev. Trend 95.63% = 7.17
9. EPS Trend 64.50% = 3.23

What is the price of EFX shares?

As of November 11, 2025, the stock is trading at USD 208.82 with a total of 891,184 shares traded.
Over the past week, the price has changed by -0.49%, over one month by -9.33%, over three months by -12.67% and over the past year by -22.39%.

Is Equifax a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Equifax (NYSE:EFX) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 68.34 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EFX is around 171.21 USD . This means that EFX is currently overvalued and has a potential downside of -18.01%.

Is EFX a buy, sell or hold?

Equifax has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy EFX.
  • Strong Buy: 11
  • Buy: 5
  • Hold: 7
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the EFX price?

Issuer Target Up/Down from current
Wallstreet Target Price 268.3 28.5%
Analysts Target Price 268.3 28.5%
ValueRay Target Price 194.4 -6.9%

EFX Fundamental Data Overview November 11, 2025

Market Cap USD = 25.56b (25.56b USD * 1.0 USD.USD)
P/E Trailing = 39.5492
P/E Forward = 23.5849
P/S = 4.3004
P/B = 5.1753
P/EG = 0.9636
Beta = 1.587
Revenue TTM = 5.94b USD
EBIT TTM = 1.10b USD
EBITDA TTM = 1.81b USD
Long Term Debt = 4.05b USD (from longTermDebt, last quarter)
Short Term Debt = 759.3m USD (from shortTermDebt, last quarter)
Debt = 4.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.62b USD (from netDebt column, last quarter)
Enterprise Value = 30.18b USD (25.56b + Debt 4.81b - CCE 189.0m)
Interest Coverage Ratio = 5.15 (Ebit TTM 1.10b / Interest Expense TTM 213.9m)
FCF Yield = 3.31% (FCF TTM 999.4m / Enterprise Value 30.18b)
FCF Margin = 16.82% (FCF TTM 999.4m / Revenue TTM 5.94b)
Net Margin = 11.08% (Net Income TTM 658.6m / Revenue TTM 5.94b)
Gross Margin = 56.26% ((Revenue TTM 5.94b - Cost of Revenue TTM 2.60b) / Revenue TTM)
Gross Margin QoQ = 57.07% (prev 56.76%)
Tobins Q-Ratio = 2.55 (Enterprise Value 30.18b / Total Assets 11.83b)
Interest Expense / Debt = 1.08% (Interest Expense 52.2m / Debt 4.81b)
Taxrate = 24.99% (53.8m / 215.3m)
NOPAT = 826.3m (EBIT 1.10b * (1 - 24.99%))
Current Ratio = 0.74 (Total Current Assets 1.46b / Total Current Liabilities 1.98b)
Debt / Equity = 0.97 (Debt 4.81b / totalStockholderEquity, last quarter 4.94b)
Debt / EBITDA = 2.55 (Net Debt 4.62b / EBITDA 1.81b)
Debt / FCF = 4.63 (Net Debt 4.62b / FCF TTM 999.4m)
Total Stockholder Equity = 4.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.57% (Net Income 658.6m / Total Assets 11.83b)
RoE = 13.29% (Net Income TTM 658.6m / Total Stockholder Equity 4.96b)
RoCE = 12.23% (EBIT 1.10b / Capital Employed (Equity 4.96b + L.T.Debt 4.05b))
RoIC = 8.37% (NOPAT 826.3m / Invested Capital 9.88b)
WACC = 10.39% (E(25.56b)/V(30.37b) * Re(12.19%) + D(4.81b)/V(30.37b) * Rd(1.08%) * (1-Tc(0.25)))
Discount Rate = 12.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.12%
[DCF Debug] Terminal Value 69.14% ; FCFE base≈913.0m ; Y1≈1.13b ; Y5≈1.92b
Fair Price DCF = 143.2 (DCF Value 17.53b / Shares Outstanding 122.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 64.50 | EPS CAGR: 11.29% | SUE: 2.03 | # QB: 3
Revenue Correlation: 95.63 | Revenue CAGR: 9.69% | SUE: 1.39 | # QB: 3

Additional Sources for EFX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle